Press Releases Search News Category Company ReleasesCompany StatementsFinancial ReleasesProduct Releases Year None2021202020192018201720162015201420132012201120102009200820072006 Date Title PDF Version Apr 04, 2019 Alexion Finalizes Settlement To Resolve Allegations Related To Support Of Patient Assistance Charities Mar 20, 2019 Alexion and Zealand Pharma Announce Collaboration to Discover and Develop Peptide Therapies for Complement-Mediated Diseases Mar 20, 2019 Alexion and Affibody Announce Partnership to Co-Develop Anti-FcRn Affibody® Molecule Mar 08, 2019 Alexion Announces Publication of Interim Data from Phase 3 Open-Label Extension Study Supporting Long-Term Efficacy and Safety of SOLIRIS® (Eculizumab) in Adult Patients with Generalized Myasthenia Gravis in Muscle & Nerve Mar 05, 2019 Alexion to Present at the Cowen 39th Annual Health Care Conference Feb 28, 2019 Alexion Employees Raise Hands to Raise Awareness and #RallyforRare on Rare Disease Day Feb 22, 2019 FDA Grants Priority Review and Accepts sBLA of SOLIRIS® (Eculizumab) as a Treatment for Patients with Neuromyelitis Optica Spectrum Disorder (NMOSD) Feb 21, 2019 Alexion to Present at the 8th Annual SVB Leerink Global Healthcare Conference Feb 12, 2019 Alexion Announces Creation of New Roles on Executive Leadership Team Feb 04, 2019 Alexion Reports Fourth Quarter and Full Year 2018 Results Pagination First page « first Previous page ‹ previous … Page 5 Page 6 Page 7 Page 8 Current page 9 Page 10 Page 11 Page 12 Page 13 … Next page next › Last page last » Displaying 81 - 90 of 598